Press Releases Innoveren Scientific Inc.

Equities

IVRN

US4041243076

Market Closed - OTC Markets Other stock markets 12:21:24 2024-05-13 pm EDT			5-day change	1st Jan Change
0.0055 ^USD	-72.50%		-.--%	-95.26%

Mar. 06	Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	CI
2023	Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Innoveren Scientific : Announces Corporate Update - Form 8-K	May. 22	PU
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-04-18	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-03-02	AQ
H-CYTE Completes Acquisition of SkinDisc™ Regenerative Tissue Kit from Scion Solutions, LLC	22-12-29	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	22-12-28	AQ
H-CYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-14	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	22-10-07	AQ
H-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 Days	22-09-19	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-09-14	AQ
H-CYTE Completes Acquisition of Jantibody	22-09-08	AQ
H-CYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-12	AQ
H-CYTE to Expect the Completed Acquisition of Jantibody Within 30 Days	22-07-22	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-06-16	AQ
H-CYTE Announces 1-for-1,000 Reverse Stock Split	22-06-13	AQ
H-CYTE, INC. : Other Events (form 8-K)	22-06-09	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-05-10	AQ
H-CYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-05-04	AQ
H-CYTE, INC. : Other Events (form 8-K)	22-04-04	AQ
H-CYTE Announces Proceeds of $1.05 Million from Warrant Exercise	22-03-04	AQ
H-CYTE, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	22-03-02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Innoveren Scientific Inc.

Equities

IVRN

US4041243076

Press Releases

Filters